Mustang Bio Stock (NASDAQ: MBIO) stock price, news, charts, stock research, profile.
Open | $0.132 |
Close | - |
Volume / Avg. | 438.168K / 3.095M |
Day Range | 0.129 - 0.135 |
52 Wk Range | 0.128 - 8.170 |
Market Cap | $3.812M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 0.97% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mustang Bio (NASDAQ: MBIO) through any online brokerage.
Other companies in Mustang Bio’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by HC Wainwright & Co. on Thursday, May 16, 2024. The analyst firm set a price target for 2.00 expecting MBIO to rise to within 12 months (a possible 1437.28% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Mustang Bio (NASDAQ: MBIO) is $0.1301 last updated Today at June 11, 2024 at 10:29 AM EDT.
There are no upcoming dividends for Mustang Bio.
Mustang Bio’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Mustang Bio.
Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.